Tom Marjot
banner
tom-marjot.bsky.social
Tom Marjot
@tom-marjot.bsky.social
Liver doctor. NIHR Academic Clinical Lecturer at University of Oxford. Interested in #MASLD, #circadian rhythms, & #sleep. #EASL YI Taskforce.
Really nice to be hosting the BASL #MASLD SIG at Jesus College Oxford on 5th September

📢Attendance is FREE and registration is EASY. There are still a few spaces left.
🔗(tinyurl.com/4j8esadr)

Really great mix of speakers. AM = Basic/Translational science; PM = Clinical updates
August 11, 2025 at 7:36 AM
May 25, 2025 at 12:04 PM
📢Great to write this review for Hep Comms with Matt Armstrong & @jonathanstinemd.bsky.social

💪We've covered everything you need to know about #Muscle & #MASLD
- Insulin resistance
- Sarcopenia
- Myosteatosis
- Impact of weight loss drugs
- Benefits of exercise

🔗 shorturl.at/aFO1Q

#LiverSky
May 25, 2025 at 12:02 PM
Breakthroughs Beyond the Journal @jhepatology.bsky.social

🚨The liver is central to fructose-associated cancer

▶️Tumors cannot use fructose directly
▶️Liver converts to specific lipids (LPC)
▶️LPCs integrate into new cancer membranes

Can this explain link between MASLD & extra-hepatic cancer?
March 17, 2025 at 1:47 PM
1: In 2025, look out for a new section in Journal of Hepatology: "Breakthroughs Beyond the Journal". Editorial-style analyses of pivotal liver research. #LiverSky

2: My comment on work from Cell Metabolism showing that MI drives #MASH. The interaction between these two conditions works BOTH ways👇
January 2, 2025 at 12:34 PM